Falk Catalyst Research Award Program
The Catalyst Award funds high-risk, high-reward translational biomedical research targeting disease biomarkers, therapeutic targets, and novel agents with strong potential for clinical impact.
Funder: Health Resources in Action
Due Dates: June 4, 2026 (Catalyst Award application deadline)
Funding Amounts: Up to $350,000 over 1–2 years (including 10% indirect costs) per award
Summary: Supports high-risk, high-reward translational biomedical research with strong clinical impact potential, laying groundwork for future large-scale projects.
Key Information: Only invited institutions may nominate up to 2 projects per cycle; PI must be full-time faculty at the nominating institution.
Description
The Catalyst Award, managed by Health Resources in Action on behalf of the Dr. Ralph and Marian Falk Medical Research Trust, provides seed funding for innovative translational biomedical research. The program aims to address critical scientific and therapeutic challenges that can be rapidly translated into clinical practice, focusing on disease biomarkers, therapeutic targets, and development of agents to disrupt or prevent disease processes. Projects should have high translational potential and, if successful, lay the foundation for future large-scale research and significant clinical impact.
